Current Cancer Drug Targets
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 2.5 | Q3 | 39.0% | 0.726 | Q2 | 74.1% |
| 2024 | 3.5 | Q2 | 67.8% | 0.722 | Q2 | 74.5% |
| 2023 | 2.3 | Q3 | 36.5% | 0.650 | Q2 | 73.4% |
| 2022 | 3.0 | Q3 | 43.4% | 0.687 | Q2 | 76.2% |
| 2021 | 2.9 | Q4 | 41.2% | 0.732 | Q2 | 78.7% |
| 2020 | — | — | 0.972 | Q1 | 84.7% | |
| 2019 | — | — | 0.893 | Q1 | 83.0% | |
| 2018 | — | — | 0.875 | Q1 | 80.9% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1873-5576
ISSN
1568-0096
country
AEcoverage
2001-2026